search
Back to results

Telemedicine Follow-up in Primary Health Care for Diabetes-related Foot Ulcers (DiaFOTo)

Primary Purpose

Diabetic Foot, Foot Ulcer

Status
Active
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Telemedicine follow-up care
Sponsored by
Helse Stavanger HF
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetic Foot focused on measuring Diabetic Foot, Diabetes Mellitus, Foot Ulcer, Wound Healing, Delivery of Health Care, Depression, sequela, Sick Leave, Quality of Life, Amputation, Legg ulcer, Hospitalization, Health Economics

Eligibility Criteria

20 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • people with type 1 or type 2 diabetes with a new foot ulcer presenting for the first time within a period of 6 months and people without diabetes presenting a venous leg ulcer
  • The participants must be able to read and speak Norwegian.
  • The participants must be 20 years or older.

Exclusion Criteria:

- people treated for an diabetes foot ulcer on the ipsilateral foot during the past 6 months in specialist health care

Sites / Locations

  • Stavanger HF
  • Haukeland University Hospital
  • Stord Hospital, Helse Fonna HF

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Active Comparator

Arm Label

Traditional follow-up

Telemedicine follow-up care

Arm Description

Traditional follow-up with standard consultations at the Section of Endocrinology. For some patients, this will include follow-up from nurses in the home care or general practice office related to wound care. However, this is not the standard procedure and will not take place in combination with telemedicine follow-up.

Telemedicine follow-up care for people with diabetes-related foot ulcers in municipal primary health care in collaboration with specialist health care

Outcomes

Primary Outcome Measures

healing time for leg ulcer and/or diabetes related foot ulcer
Healing time for leg ulcer and/or diabetes related foot ulcer measured from the time the person is included in the study until the foot ulcer is healed or the study ends (after 12 months). The effect will be measured in terms of hazard ratios (HR) and sub-hazard ratio (SHR) with healing as the endpoint and non-inferiority will be defined as <40% increased healing time in the TM-group, i.e. the lower 95% confidence limit should not be lower than 0.60.

Secondary Outcome Measures

Total number of consultations per patient
Number of consultations from baseline until the foot ulcer has healed
sequela directly related to the foot ulcer
From baseline until the foot ulcer has healed sequelae directly related to the foot ulcer: infection, hospitalization, osteomyelitis and vascular surgery during the study
Diabetes-related stress
Diabetes-related stress, measured by using the Problem Areas in Diabetes. Measured at baseline and when the ulcer has healed (or the end of the study)
Symptoms of anxiety and depression
symptoms of anxiety and depression, measured by using the Hospital Anxiety and Depression Scale at baseline and the end of the study.
Nordic Patient Experiences Questionnaire
Patient satisfaction with health care, measured by using the Nordic Patient Experiences Questionnaire. Measured at baseline and the end of the study.
EQ-5D
Health status and cost utility, measured by using the EQ-5D from the EuroQol Group at baseline and the end of the study.
Sick leave
Sick leave (number of days with a medical certificate) measured by obtaining data from the Norwegian Sick Leave Registry measured from baseline unntil the ulcer is healed (or at the end of the study)
A new foot ulcer appears, the incidence of amputation and survival.
The time elapsing before a new foot ulcer appears, the incidence of amputation and survival.

Full Information

First Posted
October 17, 2012
Last Updated
April 19, 2023
Sponsor
Helse Stavanger HF
Collaborators
Helse Vest, Norwegian Diabetes Association, Bergen University College, The Research Council of Norway, Norwegian Nurses Organisation
search

1. Study Identification

Unique Protocol Identification Number
NCT01710774
Brief Title
Telemedicine Follow-up in Primary Health Care for Diabetes-related Foot Ulcers
Acronym
DiaFOTo
Official Title
Effect of Telemedicine Follow-up Care in Primary Health Care Versus Traditional Follow-up in Specialist Health Care on the Healing Time for Diabetes-related Foot Ulcers - a Cluster-randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
June 2021
Overall Recruitment Status
Active, not recruiting
Study Start Date
April 2012 (Actual)
Primary Completion Date
June 2022 (Actual)
Study Completion Date
December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Helse Stavanger HF
Collaborators
Helse Vest, Norwegian Diabetes Association, Bergen University College, The Research Council of Norway, Norwegian Nurses Organisation

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will investigate whether telemedicine follow-up care for people with diabetes-related foot ulcers and people with leg ulcers (without diabetes) in municipal primary health care in collaboration with specialist health care is an equivalent alternative to traditional outpatient clinical follow-up in specialist health care (noninferiority trial) in relation to healing time.
Detailed Description
The increasing prevalence of diabetes, especially type 2 diabetes, combined with a steadily increasing proportion of older people in the population, will present enormous challenges for health care services and the individual with diabetes in Norway. Therefore, health care services need to rapidly begin treatment for people with diabetes-related foot ulcers to ensure high-quality treatment. Telemedicine innovations for health care services have developed considerably in recent decades. The National Health Plan for Norway (2007-2010) emphasizes that the use of information and communication technologies is an important way of achieving health policy aims in establishing more integrated diagnosis, treatment and care pathways across organizational boundaries. Qualitative studies of diabetes-related foot ulcers have shown that using telemedicine equipment enables follow-up care of similar quality to traditional consultations while enabling more flexible organization and greater patient satisfaction. A few minor quantitative studies show positive gains when telemedicine equipment is used in following up diabetes-related foot ulcers, but no randomized controlled studies have been performed in this field. Further, studies focusing on the more long-term effects are lacking. The project is in accordance with national guidelines and will contribute to increasing the focus on research related to integrated care. The investigators expect this project to provide evidence about alternative care pathways with a holistic approach that could moderate increases in the cost of health care services by delivering a larger proportion of services in municipal primary care. The project will be able to provide new evidence on meeting the challenges of diabetes-related care more systematically and proactively. The investigators expect that the results of this study will contribute to showing the extent to which treatment at the lowest effective service level will be more cost-effective and of good or better quality than traditional clinical follow-up. This study can and will contribute to setting priorities for the users' needs for flexible health services and enabling more patients to be treated near their homes. If the study finds evidence of positive health gains for the individual people with diabetes and contributes to high quality of care, this new model can be implemented in the entire Stavanger Hospital Trust. This approach will enable the multidisciplinary team in specialist health care to be used more appropriately, and the team will be more accessible for health care personnel in municipal primary health care. This model can be transferred to other hospital trusts and contribute to improving knowledge on diabetes among nurses in municipal primary health care. The main study confirmed that TM was non-inferior in traditional treatment with regard to healing time (primary outcome). The TM group had a significantly lower proportion of amputations, and there were no significant differences in the proportion of deaths, number of consultations, or patient satisfaction between groups, although the direction of the effect estimates for these clinical outcomes favored the TM group. There is a need to continue the study with additional patients to gain more knowledge about the extent to which the telemedicine follow-up affects the number of consultations (secondary outcome), inclusion of participants during 2019-2021. In addition, there is a need for more knowledge about the effect of telemedicine follow-up for patients with leg ulcers and in people without diabetes. The investigators have used qualitative interview as a process evaluation in this study and will investigate process variables more systematically in the further follow-up. By examining how the services are organized (organization and structure) the investigators will gain knowledge how the variation in the organization of telemedicine follow-up is affecting the outcome.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetic Foot, Foot Ulcer
Keywords
Diabetic Foot, Diabetes Mellitus, Foot Ulcer, Wound Healing, Delivery of Health Care, Depression, sequela, Sick Leave, Quality of Life, Amputation, Legg ulcer, Hospitalization, Health Economics

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
241 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Traditional follow-up
Arm Type
No Intervention
Arm Description
Traditional follow-up with standard consultations at the Section of Endocrinology. For some patients, this will include follow-up from nurses in the home care or general practice office related to wound care. However, this is not the standard procedure and will not take place in combination with telemedicine follow-up.
Arm Title
Telemedicine follow-up care
Arm Type
Active Comparator
Arm Description
Telemedicine follow-up care for people with diabetes-related foot ulcers in municipal primary health care in collaboration with specialist health care
Intervention Type
Procedure
Intervention Name(s)
Telemedicine follow-up care
Intervention Description
Telemedicine follow-up care for people with diabetes-related foot ulcers in municipal primary health care in collaboration with specialist health care
Primary Outcome Measure Information:
Title
healing time for leg ulcer and/or diabetes related foot ulcer
Description
Healing time for leg ulcer and/or diabetes related foot ulcer measured from the time the person is included in the study until the foot ulcer is healed or the study ends (after 12 months). The effect will be measured in terms of hazard ratios (HR) and sub-hazard ratio (SHR) with healing as the endpoint and non-inferiority will be defined as <40% increased healing time in the TM-group, i.e. the lower 95% confidence limit should not be lower than 0.60.
Time Frame
one year
Secondary Outcome Measure Information:
Title
Total number of consultations per patient
Description
Number of consultations from baseline until the foot ulcer has healed
Time Frame
one year
Title
sequela directly related to the foot ulcer
Description
From baseline until the foot ulcer has healed sequelae directly related to the foot ulcer: infection, hospitalization, osteomyelitis and vascular surgery during the study
Time Frame
one year
Title
Diabetes-related stress
Description
Diabetes-related stress, measured by using the Problem Areas in Diabetes. Measured at baseline and when the ulcer has healed (or the end of the study)
Time Frame
one year
Title
Symptoms of anxiety and depression
Description
symptoms of anxiety and depression, measured by using the Hospital Anxiety and Depression Scale at baseline and the end of the study.
Time Frame
one year
Title
Nordic Patient Experiences Questionnaire
Description
Patient satisfaction with health care, measured by using the Nordic Patient Experiences Questionnaire. Measured at baseline and the end of the study.
Time Frame
one year
Title
EQ-5D
Description
Health status and cost utility, measured by using the EQ-5D from the EuroQol Group at baseline and the end of the study.
Time Frame
one year
Title
Sick leave
Description
Sick leave (number of days with a medical certificate) measured by obtaining data from the Norwegian Sick Leave Registry measured from baseline unntil the ulcer is healed (or at the end of the study)
Time Frame
one year
Title
A new foot ulcer appears, the incidence of amputation and survival.
Description
The time elapsing before a new foot ulcer appears, the incidence of amputation and survival.
Time Frame
2 and 3 years after the end of the study

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: people with type 1 or type 2 diabetes with a new foot ulcer presenting for the first time within a period of 6 months and people without diabetes presenting a venous leg ulcer The participants must be able to read and speak Norwegian. The participants must be 20 years or older. Exclusion Criteria: - people treated for an diabetes foot ulcer on the ipsilateral foot during the past 6 months in specialist health care
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marjolein M. Iversen, PhD
Organizational Affiliation
Helse Stavanger HF
Official's Role
Principal Investigator
Facility Information:
Facility Name
Stavanger HF
City
Stavanger
State/Province
Rogaland
ZIP/Postal Code
4068
Country
Norway
Facility Name
Haukeland University Hospital
City
Bergen
Country
Norway
Facility Name
Stord Hospital, Helse Fonna HF
City
Leirvik
Country
Norway

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
33087074
Citation
Iversen MM, Igland J, Smith-Strom H, Ostbye T, Tell GS, Skeie S, Cooper JG, Peyrot M, Graue M. Effect of a telemedicine intervention for diabetes-related foot ulcers on health, well-being and quality of life: secondary outcomes from a cluster randomized controlled trial (DiaFOTo). BMC Endocr Disord. 2020 Oct 21;20(1):157. doi: 10.1186/s12902-020-00637-x.
Results Reference
derived
PubMed Identifier
29187423
Citation
Smith-Strom H, Igland J, Ostbye T, Tell GS, Hausken MF, Graue M, Skeie S, Cooper JG, Iversen MM. The Effect of Telemedicine Follow-up Care on Diabetes-Related Foot Ulcers: A Cluster-Randomized Controlled Noninferiority Trial. Diabetes Care. 2018 Jan;41(1):96-103. doi: 10.2337/dc17-1025. Epub 2017 Nov 29.
Results Reference
derived
PubMed Identifier
27573312
Citation
Smith-Strom H, Iversen MM, Graue M, Skeie S, Kirkevold M. An integrated wound-care pathway, supported by telemedicine, and competent wound management-Essential in follow-up care of adults with diabetic foot ulcers. Int J Med Inform. 2016 Oct;94:59-66. doi: 10.1016/j.ijmedinf.2016.06.020. Epub 2016 Jun 29.
Results Reference
derived
PubMed Identifier
27430301
Citation
Iversen MM, Espehaug B, Hausken MF, Graue M, Ostbye T, Skeie S, Cooper JG, Tell GS, Gunther BE, Dale H, Smith-Strom H, Kolltveit BC, Kirkevold M, Rokne B. Telemedicine Versus Standard Follow-Up Care for Diabetes-Related Foot Ulcers: Protocol for a Cluster Randomized Controlled Noninferiority Trial (DiaFOTo). JMIR Res Protoc. 2016 Jul 18;5(3):e148. doi: 10.2196/resprot.5646.
Results Reference
derived
PubMed Identifier
27091459
Citation
Kolltveit BC, Gjengedal E, Graue M, Iversen MM, Thorne S, Kirkevold M. Telemedicine in diabetes foot care delivery: health care professionals' experience. BMC Health Serv Res. 2016 Apr 18;16:134. doi: 10.1186/s12913-016-1377-7.
Results Reference
derived

Learn more about this trial

Telemedicine Follow-up in Primary Health Care for Diabetes-related Foot Ulcers

We'll reach out to this number within 24 hrs